NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Vivek Subbiah's statement confirms that NWBO submitted their Abstract through the standard ASCO procedure -- not the (TIP) 'Trial in Progress' Procedure. Had they gone the TIP route, Vivek would be restricted from sharing ongoing data at his ASCO presentation. MD Anderson knows the rules better than anyone else.

This is really good news. For those of you who were around last year, there was even a chance he was going to present data at a different conference last fall, but the slow start for first-in-human studies made this untenable. Consequently, I feel very confident he will share data at ASCO. The fact that it is now late February 2014 when he is making this statement carries a great deal more meaning.